Skip to Content

CIBA LN (Metopirone 250 mg)

Generic Name: metyrapone

Pill with imprint CIBA LN is White, Capsule-shape and has been identified as Metopirone 250 mg. It is supplied by Novartis Pharmaceuticals Corporation.

Metopirone is used in the treatment of diagnosis and investigation and belongs to the drug classes adrenal corticosteroid inhibitors, in vivo diagnostic biologicals. Risk cannot be ruled out during pregnancy. Metopirone 250 mg is not a controlled substance under the Controlled Substance Act (CSA).

Images for CIBA LN

Metopirone

Generic Name:
metyrapone
Imprint:
CIBA LN
Strength:
250 mg
Color:
White
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Adrenal corticosteroid inhibitors
In vivo diagnostic biologicals
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Novartis Pharmaceuticals Corporation
National Drug Code (NDC):
00078-0455

Get help with Imprint Code FAQs.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide